Key facts
- It has raised $3.3M; the latest was Seed Round ($3.0M) in Oct 2024.
- Notable investors include T-Hub, Venture Catalysts, z21 Ventures, Whiteboard Capital, Aditya Damani — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Perceptyne
- ·The full record, as it builds
Funding rounds
No funding rounds for Perceptyne are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Perceptyne
Developer of multi-utility robotic arms designed for the automation of tasks. The company's products have many features, including three-dimensional image sensors, articulated hands with in-built actuators, and AI-enabled tactile sensing that can be used for product assembly, kitchen automation, packing, and machine tending, enabling businesses to get a dual-arm robot that can achieve human-like functionality at an affordable cost.
- Sector
- Information Technology
- HQ
- Hyderabad, India
- Founded
- 2021
- Employees
- 33
- Website
- perceptyne.com/
- Ownership
- Privately Held (backing)
Perceptyne doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Perceptyne shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Perceptyne in its N-PORT filings yet. We sweep new filings monthly.